Read More

Walgreens in the Crosshairs: FDA Warnings Lead to Consumer Lawsuit Over Risky Eye Drops

Walgreens Boots Alliance Inc (NASDAQ: WBA) is in hot water as it grapples with a proposed class action lawsuit in Florida federal court alleging that the pharmacy retailer mislabeled eyedrops designed to treat pink eye (conjunctivitis), misleading consumers into believing the product was safe and effect

WBA

Read More

SEC Says Goldman To Pay SEC $6M In Penalties For Providing Deficient Blue Sheet Data

https://www.sec.gov/news/press-release/2023-191   The Securities and Exchange Commission today announced settled charges against Goldman Sachs & Co. LLC for failing to provide complete and accurate securities trading information, known as blue sheet data, to the SEC. Goldman agreed to pay a $6 million penalty to resolve the SEC's charges.  

GS